Analytical Data
-
Gene name
BT_1622
- Application
-
Alternative Names
Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50); Hydrolase
-
Species
Others
-
Source
E. coli
-
Tag
His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8A7A3
-
Expression Region
Q21-F500
-
Protein Length
Full Length of Mature Protein (with Propeptide)
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BT_1622 is a recombinant protein that has garnered significant attention due to its potential applications in various fields, including biotechnology and medicine. Research surrounding BT_1622 focuses on its structural properties, biological functions, and mechanisms of action. This protein is derived from a specific organism, and its unique characteristics make it a valuable candidate for studying protein interactions, enzymatic activities, and therapeutic potentials. Scholars have been investigating its role in cellular processes, such as signaling pathways and metabolic regulation, as well as its implications in disease models. In particular, BT_1622 has been linked to immune responses, and understanding its interaction with immune cells may open new avenues for vaccine development or targeted therapies. The recombinant production of BT_1622 allows for higher yields and the opportunity to modify its properties for enhanced functionality. Ongoing studies aim to elucidate its three-dimensional structure, which is crucial for understanding its activity and for designing novel applications. Overall, BT_1622 represents a fascinating subject of research that bridges fundamental biology and practical applications, making it a pivotal focus for future studies in the realms of molecular biology and therapeutic innovation.
